In this CREST module, "How to Manage Rectal GIST" get a review of GIST tumors,

arise from interstitial cells of Cajal and stain for CD117 antigen, a marker for KIT tyrosine kinase oncoprotein. Imatinib targets this oncoprotein and is the drug of choice for the treatment of GIST. Rectal GIST represents 5% of all GIST and the first line of treatment is surgical excision. Frequently these tumors also require neoadjuvant therapy in order to obtain negative margins and downsize the tumor, or postoperatively in the adjuvant setting.

Upon completion of this module, participants should be able to:

• Describe the main features of GIST tumors.
• Evaluate surgical indications for rectal GIST.
• Describe types of surgery for rectal GIST based on location and size.
• Evaluate the role of neoadjuvant vs. adjuvant therapy in the management of rectal GIST.

As a Core Subject, it is eligible for 1 AMA PRA Category 1 Credits™.

The ASCRS Online Learning Center provides access to both CREST and CARSEP. Using your ASCRS website login, you will have access to up-to-date information on colorectal diseases.

This CREST weekly module will provide the learner a high level overview of Lynch Syndrome. The module will cover epidemiology, genetics, diagnosis, treatment, surveillance, familial testing, and lynch and lynch-like syndromes. At completion the learner should have a good understanding of how to screen, survey, and effectively treat patients with Lynch Syndrome.

As a Core Subject, it is eligible for 1 AMA PRA Category 1 Credits™.

CME Credit Hours Available: 1 hour
Member Price: $10.00

Click here to enroll in this CREST Weekly Module.

The ASCRS Online Learning Center provides access to both CREST and CARSEP. Using your ASCRS website login, you will have access to up-to-date information on colorectal diseases.

This CREST Weekly module discusses the role of biologic agents in IBD, focusing on the new biologic agents, their efficacy and limitations.

Upon completion of this module, participants should be able to:

• Identify newer biologics used in IBD.
• Identify mechanisms of action of newer biologics.
• Review efficacy and future developments.

As a Weekly Curriculum module, it is eligible for 1 AMA PRA Category 1 Credit™.

The ASCRS Online Learning Center provides access to both CREST and CARSEP. Using your ASCRS website login, you will have access to up-to-date information on colorectal diseases.

This CREST weekly module will provide an overview on constipation. Constipation is a very common condition, and it is divided into 3 categories: Slow transit constipation, constipation predominant - irritable bowel syndrome and pelvic obstructive constipation. Adequate diagnosis and classification of the constipation is essential in its management, therefore selecting the right test is key. Among the tests most frequently used in the diagnosis of constipation, we can mention sitz mark colonic transit study, scintigraphy, capsule study, anal manometry and defecography.

As a Core Subject, it is eligible for 1 AMA PRA Category 1 Credits™.

CME Credit Hours Available: 1 hour
Member Price: $10.00
Nonmember Price: $15.00

Click here to enroll in this CREST Weekly Module.

The ASCRS Online Learning Center provides access to both CREST and CARSEP. Using your ASCRS website login, you will have access to up-to-date information on colorectal diseases.

Access this CREST module for an update on outcomes and techniques for ventral mesh rectopexy.

Upon completion of this module, participants should be able to:

• Define the etiology of rectal prolapse and its relationship to outlet dysfunction syndrome.
• Discuss the indications for surgery and types of surgery done in the past.
• Review the recent literature on outcomes and complications (specifically recurrence rates).
• Explain the steps that should be followed in ventral mesh rectopexy.

As a CREST Weekly Curriculum, it is eligible for 1 AMA PRA Category 1 Credit™.

The ASCRS Online Learning Center provides access to both CREST and CARSEP. Using your ASCRS website login, you will have access to up-to-date information on colorectal diseases.